Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure

Many second-line therapies are recently approved for patients with advanced hepatocellular carcinoma (HCC), in whom protein malnutrition is prevalent that would affect treatment outcomes. In this study, we aimed to investigate the role of pre-sarcopenia and muscle restoration in patients with sorafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tsung-Yi, Lee, Pei-Chang, Chen, Yi-Tzen, Chao, Yee, Hou, Ming-Chih, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591538/
https://www.ncbi.nlm.nih.gov/pubmed/33110117
http://dx.doi.org/10.1038/s41598-020-75198-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591538/
https://www.ncbi.nlm.nih.gov/pubmed/33110117
http://dx.doi.org/10.1038/s41598-020-75198-z

Ejemplares similares